Assessment of Knowledge and Practice of Healthcare Providers in Saudi Arabia Regarding Clostridioides difficile Infection Diagnosis and Management: A Cross-Sectional Questionnaire-Based Study

References

• Abt MC, McKenney PT, Pamer EG. Clostridium difficile colitis: pathogenesis and host defence. Nat Rev Microbiol. 2016;14(10):609–620. doi:10.1038/nrmicro.2016.108
   PubMed Web of Science ®Google Scholar
• Khanafer N, Vanhems P, Barbut F, et al. Factors associated with clostridium difficile infection: a nested case-control study in a three year prospective cohort. Anaerobe. 2017;44:117–123. doi:10.1016/j.anaerobe.2017.03.003
   PubMed Web of Science ®Google Scholar
• Regnault H, Bourrier A, Lalande V, et al. Prevalence and risk factors of clostridium difficile infection in patients hospitalized for flare of inflammatory bowel disease: a retrospective assessment. Dig Liver Dis. 2014;46(12):1086–1092. doi:10.1016/j.dld.2014.09.003
   PubMedGoogle Scholar
• Norris AH, Shrestha NK, Allison GM, et al. 2018 infectious diseases society of America clinical practice guideline for the management of outpatient parenteral antimicrobial therapy. Clin Infect Dis. 2019;68(1):e1–e35. doi:10.1093/cid/ciy745
   PubMed Web of Science ®Google Scholar
• Crobach MJ, Planche T, Eckert C, et al. European Society of clinical microbiology and infectious diseases: update of the diagnostic guidance document for clostridium difficile infection. Clin Microbiol Infect. 2016;22(Suppl 4:):S63–81. doi:10.1016/j.cmi.2016.03.010
   PubMed Web of Science ®Google Scholar
• McDonald LC, Gerding DN, Johnson S, et al. Clinical practice guidelines for clostridium difficile infection in adults and children: 2017 Update by the Infectious Diseases Society of America (IDSA) and society for healthcare epidemiology of America (SHEA). Clin Infect Dis. 2018;66(7):e1–e48. doi:10.1093/cid/cix1085
   PubMed Web of Science ®Google Scholar
• Guh AY, Mu Y, Winston LG, et al. Trends in U.S. burden of clostridioides difficile infection and outcomes. New England J Med. 2020;382(14):1320–1330. doi:10.1056/NEJMoa1910215
   PubMed Web of Science ®Google Scholar
• Alzouby S, Baig K, Alrabiah F, et al. Clostridioides difficile infection: incidence and risk factors in a tertiary care facility in Riyadh, Saudi Arabia. J Infect Public Health. 2020;13(7):1012–1017. doi:10.1016/j.jiph.2019.10.014
   PubMed Web of Science ®Google Scholar
• Aljafel NA, Al-Shaikhy HH, Alnahdi MA, et al. Incidence of Clostridioides difficile infection at a Saudi tertiary academic medical center and compliance with IDSA/SHEA, ACG, and ESCMID guidelines for treatment over a 10-year period. J Infect Public Health. 2020;13(8):1156–1160. doi:10.1016/j.jiph.2020.03.007
   PubMed Web of Science ®Google Scholar
• Stofkova Z, Novakova E, Sadlonova V. Survey on the diagnosis and treatment of Clostridium difficile infection. Bratisl Lek Listy. 2020;121(12):840–846. doi:10.4149/BLL_2020_138
   PubMed Web of Science ®Google Scholar
• Fayerberg E, Bouchard J, Kellie SM. Knowledge, attitudes and practice regarding Clostridium difficile: a survey of physicians in an academic medical center. Am J Infect Control. 2013;41(3):266–269. doi:10.1016/j.ajic.2012.03.013
   PubMed Web of Science ®Google Scholar
• Ferguson JK, Cheng AC, Gilbert GL, et al. Clostridium difficile laboratory testing in Australia and New Zealand: national survey results and Australasian society for infectious diseases recommendations for best practice. Pathology. 2011;43(5):482–487. doi:10.1097/PAT.0b013e328348c9b4
   PubMed Web of Science ®Google Scholar
• Alcalá L, Marín M, Martín A, et al. Laboratory diagnosis of clostridium difficile infection in Spain: a population-based survey. J Hosp Infect. 2011;79(1):13–17. doi:10.1016/j.jhin.2011.05.017
   PubMed Web of Science ®Google Scholar
• Chung H-S, Park JS, Shin B-M. Laboratory diagnosis of clostridium difficile infection in Korea: the first national survey. Ann Lab Med. 2019;39(3):317–321. doi:10.3343/alm.2019.39.3.317
   PubMed Web of Science ®Google Scholar
• Kociolek LK, Kutty PK, Polgreen PM, et al. Healthcare provider diagnostic testing practices for identification of clostridioides (clostridium)difficile in children: an emerging infections network survey. Infect Control Hosp Epidemiol. 2019;40(3):276–280. doi:10.1017/ice.2018.347
   PubMed Web of Science ®Google Scholar
• Almohammed OA, Aldwihi LA, Alragas AM, et al. Knowledge, attitude, and practices associated with COVID-19 among healthcare workers in hospitals: a cross-sectional study in Saudi Arabia. Front Public Health. 2021;9:643053. doi:10.3389/fpubh.2021.643053
   PubMed Web of Science ®Google Scholar
• Swed S, Bohsas H, Patwary MM, et al. Knowledge of mpox and its determinants among the healthcare personnel in Arabic regions: a multi-country cross-sectional study. New Microbes New Infect. 2023;54:101146. doi:10.1016/j.nmni.2023.101146
   PubMed Web of Science ®Google Scholar
• Legenza L, Barnett S, Rose W, et al. Clostridium difficile infection perceptions and practices: a multicenter qualitative study in South Africa. Antimicrob Resist Infect Control. 2018;7(1):125. doi:10.1186/s13756-018-0425-y
   PubMedGoogle Scholar
• Bishop PA, Isache C, McCarter YS, et al. Clinical impact of a pharmacist-led antimicrobial stewardship initiative evaluating patients with clostridioides difficile colitis. J Invest Med. 2020;68(4):888–892. doi:10.1136/jim-2019-001173
   PubMed Web of Science ®Google Scholar
• Polisetty RS, Hoff BM, Moore WJ, et al. 180. Impact of a two-step diagnostic bundle on hospital-onset clostridioides difficile infection rates and treatment across a large health system. Open Forum Infect Diseases. 2022;9(Supplement_2): doi:10.1093/ofid/ofac492.258
   Google Scholar
• Blythe D, Blythe D, Bork J, et al. SPARC-ing change—the Maryland statewide prevention and reduction of clostridioides difficile (SPARC) collaborative. Infect Control Hosp Epidemiol. 2020;41(S1):s80–s80. doi:10.1017/ice.2020.571
   PubMedGoogle Scholar
• Aroori S, Blencowe N, Pye G, et al. Clostridium difficile: how much do hospital staff know about it? Ann R Coll Surg Engl. 2009;91(6):464–469. doi:10.1308/003588409X432310
   PubMed Web of Science ®Google Scholar
• Johnson S, Lavergne V, Skinner AM, et al. Clinical practice guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of clostridioides difficile infection in adults. Clin Infect Dis. 2021;73(5):e1029–e1044. doi:10.1093/cid/ciab549
   PubMed Web of Science ®Google Scholar
• Finnimore K, Smyth W, Carrucan J, et al. Nurses’ knowledge, practices and perceptions regarding Clostridioides difficile: survey results. Infect Dis Health. 2023;28(1):39–46. doi:10.1016/j.idh.2022.07.003
   PubMed Web of Science ®Google Scholar
• Comparcini D, Simonetti V, Segala FV, et al. Nurses’ knowledge, attitudes and practices on the management of clostridioides difficile infection: a cross-sectional study. Antibiotics (Basel). 2023;12(3): doi:10.3390/antibiotics12030529
   PubMed Web of Science ®Google Scholar
• Almutairi MS, Gonzales-Luna AJ, Alnezary FS, et al. Comparative clinical outcomes evaluation of hospitalized patients infected with Clostridioides difficile ribotype 106 vs. other toxigenic strains. Anaerobe. 2021;72:102440. doi:10.1016/j.anaerobe.2021.102440
   PubMed Web of Science ®Google Scholar
• Thabit AK, Aljedaani HJ, Alghamdi RH, et al. An insight into clostridioides difficile-associated diarrhea in Saudi children: diagnosis and treatment. Expert Rev Gastroenterol Hepatol. 2023;17(8):805–810. doi:10.1080/17474124.2023.2240704
   PubMed Web of Science ®Google Scholar